BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 91570)

  • 1. Purification of the subunit Clq from the first component of equine complement.
    McDonald TL; Burger D
    Immunology; 1979 Jul; 37(3):517-27. PubMed ID: 91570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1q: isolation from human serum in high yield by affinity chromatography and development of a highly sensitive hemolytic assay.
    Kolb WP; Kolb LM; Podack ER
    J Immunol; 1979 May; 122(5):2103-11. PubMed ID: 109524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of immune complexes by an equine Clq-like factor.
    McDonald TL
    Immunol Commun; 1981; 10(8):741-52. PubMed ID: 6176533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical and functional characterization of the C1r subunit of the first complement component.
    Ziccardi RJ; Cooper NR
    J Immunol; 1976 Feb; 116(2):496-503. PubMed ID: 814163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rat Clq: isolation and purification from normal serum and development of a sensitive hemolytic assay.
    Leung K; Kerr JS
    Immunol Invest; 1985 Aug; 14(4):283-98. PubMed ID: 3877681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of myeloperoxidase from equine polymorphonuclear leucocytes.
    Mathy-Hartert M; Bourgeois E; Grülke S; Deby-Dupont G; Caudron I; Deby C; Lamy M; Serteyn D
    Can J Vet Res; 1998 Apr; 62(2):127-32. PubMed ID: 9553712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further studies on the identification of the subcomponents of the first component of complement after affinity chromatography of human serum on IgG-sepharose.
    Taylor PA; Fink S; Bing DH; Painter RH
    J Immunol; 1977 May; 118(5):1722-7. PubMed ID: 858917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of pig Clq and its structural and functional characterization.
    Simecková J; Dlabac V; Stránský J
    Vet Immunol Immunopathol; 1985 Jun; 9(2):115-30. PubMed ID: 3898551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The first component of complement. I. Purification and properties of native C1.
    Medicus RG; Chapuis RM
    J Immunol; 1980 Jul; 125(1):390-5. PubMed ID: 7381205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obtaining of pure transferrins D, M and R from equine serum and determination of transferrin level in relation to phenotype.
    Didkowski S; Kaminski M; Kerjan P; Tomaszewska-Guszkiewicz K; Zurkowski M
    Acta Physiol Pol; 1984; 35(5-6):529-38. PubMed ID: 6545995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of circulating antigen-antibody complexes by their inhibitory effect on the agglutination of IgG-coated particles by rheumatioid factor of Clq.
    Lurhuma AZ; Cambiaso CL; Masson PL; Heremans JF
    Clin Exp Immunol; 1976 Aug; 25(2):212-26. PubMed ID: 954232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of estrogen receptors from MCF-7 human breast cancer cells.
    Chong MT; Lippman M
    Cancer Res; 1980 Sep; 40(9):3172-6. PubMed ID: 7427936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and heterogeneity of human kininogen. Use of DEAE-chromatography, molecular sieving and antibody specific immunosorbents.
    Hamberg U; Elg P; Nissinen E; Stelwagen P
    Int J Pept Protein Res; 1975; 7(3):261-80. PubMed ID: 1158563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and purification of human C1q from plasma.
    Pohl DA; Gibbons JJ; Tsai CC; Roodman ST
    J Immunol Methods; 1980; 36(1):13-27. PubMed ID: 7204993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stepwise dissociation of subcomponents of C1, the first component of human complement, upon activation on an affinity sorbent].
    Kozlov LV; Shoĭbonov BB; Ivanov AE; Zubov VP; Antonov VK
    Biokhimiia; 1989 Oct; 54(10):1745-51. PubMed ID: 2605275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fifth component of guinea pig complement: purification and characterization.
    Kinoshita T; Hong K; Kondo K; Inoue K
    J Immunol; 1981 Jun; 126(6):2414-8. PubMed ID: 7229382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of the terminal complement complex from target sheep erythrocyte membranes.
    Bhakdi S; Ey P; Bhakdi-Lehnen B
    Biochim Biophys Acta; 1976 Feb; 419(3):445-57. PubMed ID: 1247570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on circulating immune complexes of the liver disease. 3. Conditions for Clq binding assay and low molecular weight Clq reactants.
    Arima T; Narumoto J; Shimomura H; Suwaki K; Kunishi K; Yasuhara T; Nagashima H
    Gastroenterol Jpn; 1980; 15(1):20-6. PubMed ID: 6153627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rat Clq: similarity to human Clq in functional and compositional properties.
    Höffken K; McLaughlin PJ; Price MR; Preston VE; Baldwin RW
    Immunochemistry; 1978 Jun; 15(6):409-12. PubMed ID: 700777
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.